期刊文献+

CHD合并DM2患者血清HMGB1与hs-CRP水平及临床意义 被引量:3

Study on the Changes of Serum HMGB1 and hs-CRP Levels in Patients with CHD Complicated with DM2
下载PDF
导出
摘要 目的:探讨血清高迁移率族蛋白1(HMGB1)与超敏C反应蛋白(hs-CRP)在冠心病(CHD)合并2型糖尿病(DM2)患者中的表达及临床意义。方法:入选20例CHD合并DM2患者(C组),30例CHD患者(B组)及30例正常对照组(A组),ELISA测HMGB1值。分析三组间HMGB1与hs-CRP及总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)之间的关系。结果:C组与B组患者的HMGB1、hs-CRP水平均显著高于A组,C组hs-CRP水平显著高于B组(P<0.05)。HMGB1水平与HDL-C呈负相关(r=-0.271,P<0.05)。结论:CHD与DM2均有慢性炎症反应参与,HMGB1升高可能与脂质代谢异常有关,HMGB1和CRP相互促进在动脉粥样硬化及糖尿病的发生、发展中起着重要作用。 Objective To study the clinical significance of changes of serum expressions of HMGB1 and hs-CRP in patients with CHD complicated with DM2.Methods Serum high mobility group box chromosomal protein 1(HMGB1,with ELISA)and hs-CRP,total cholesterol(TC),TG,HDL-C,LDL-C(with biochemistry)levels were determined in 20 patients with CHD complicated with DM2,30 patients with CHD not complicated with DM2 and 30 controls.Results The serum levels of HMGB1 and hs-CRP in the CHD patients were significantly higher than those in controls(P0.05),moreover,the hs-CRP levels in CHD patients complicated with DM2 were significantly higher than those in CHD patients not complicated with DM2(P0.05).As a whole,the HMGB1 levels were negatively correlated with the levels of HDL-C(r=-0.271,P0.05).Conclusion The increased expression of HMGB1 in these patients might be related to the derangement of lipid metabolism.HMGB1 could stimulate the secretion of hs-CRP and other imflammatory cytokines,enhancing the process of atherogenesis as well as development of diabetes.
出处 《放射免疫学杂志》 CAS 2010年第3期327-329,共3页 Journal of Radioimmanology
关键词 冠心病 2型糖尿病 高迁移率族蛋白HMGB1 高敏-C反应蛋白 coronary heart disease diabetes mellitus type 2 high mobility group box chromosomal protein 1(HMGB1) hs-CRP
  • 相关文献

参考文献12

  • 1Hansson GK. Inflammation, atherosclerosis, and coronary artery discase[J]. N Engl J Med, 2005,352:1685-1695.
  • 2Spranger J, Kroke AM, Mohlig M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective populationbased european prospective investigation into cancer and nutrition ( EPIC)-potsdam study[J]. Diabetes, 2003, 52(3) : 812-817.
  • 3Goodwin GH, Sanders C, Johns EW. A new group of ehormafin-associated proteins with a high content of acidic and basic amino acids[J]. Eur J Biochem, 1973,38(1) :14-19.
  • 4Klune JR, Dhupar R, Cardinal J, et al. HMGB1 :endogenous danger signaling[J]. Mol Med, 2008,14(7-8) :476-484.
  • 5Karlsson S, Pettil V, Tenhunen J, et al. HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis [ J ]. Intensive Care Med, 2008,34 (6) : 1046-1053.
  • 6Inoue K, Kawahara K, Biswas KK, et al. HMGB1 expression by activatecl vascular smooth muscle cells in advanced human atherosclerosis plaques[J]. Cardiovasc Pathol, 2007,16:136-143.
  • 7Porto A, Palumbo R, Pieroni M, et al. Smoothmusde cells in human atheroscle-rotic plaques secrete and proliferate in response to high mobility group box 1 protein[J]. FASEB J, 2006,20:2565-2566.
  • 8李法权,廖伟,王梦洪.高迁移率族蛋白B1与心血管疾病的关系[J].中华老年心脑血管病杂志,2009,11(1):72-74. 被引量:3
  • 9杨晓玲.2型糖尿病C反应蛋白与血脂代谢的关系[J].中国慢性病预防与控制,2009,17(2):199-199. 被引量:1
  • 10李宜川,刘国玲,孟凡良.2型糖尿病患者血清超敏C反应蛋白和低密度脂蛋白胆固醇水平的研究[J].贵阳医学院学报,2009,34(5):530-532. 被引量:3

二级参考文献62

  • 1Wang H,Bloom O,Zhang M,et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science,1999,285:248-251.
  • 2Huttunen HJ,Rauvala H. Amphoterin as an extracellular regulator of cell motility: from discovery to disease. J Intern Med, 2004,255 : 351-366.
  • 3Chen G, Li J, Qiang X, et al. Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis. J Lipid Res, 2005,46 : 623-627.
  • 4Kalinina N, Agrotis A, Antropova Y, et al. Increased expres sion of the DNA-binding cytokine HMGB1 in human athero sclerotic lesions: role of activated macrophages and cyto kines. Arterioscler Thromb Vasc Biol, 2004,24 : 2320-2325.
  • 5Inoue K, Kawahara K, Biswas KK, et al. HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques. Cardiovasc Pathol, 2007,16 : 136-143.
  • 6Abeyama K,Stern DM, Ito Y, et al. The N-terminal domain of thrombomodulin sequesters high-mobility groulp-B1 protein, a novel antiinflammatory mechanism. J Clin Invest, 2005,115 : 1267-1274.
  • 7Porto A,Palumbo R,Pieroni M, et al. Smooth muscle ceils in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein. FASEB J ,2006, 20:2565-2566.
  • 8Basra G. Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications. Atherosclerosis, 2008,196 : 9-21.
  • 9Amandine J, Sylvain T,Brigitte J, et al. Activation of sPLA2- IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-lbeta. FASEB J,2006,20:1727-1729.
  • 10Bradshaw G, Gutierrez A, Miyake JH, et al. Facilitated replacement of Kupffer cells expressing a paraoxonase-1 transgene is essential for ameliorating atherosclerosis in mice. Proe Natl Acad Sci USA, 2005,102:11029-11034.

共引文献24

同被引文献27

  • 1哈文静,严宏.炎症在糖尿病视网膜病变发病机制中的作用[J].国际眼科杂志,2005,5(4):745-749. 被引量:15
  • 2Haffner SM, Lehto S, Rnnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [ J]. N Engl J Med, 1998,339 (4) :229 - 234.
  • 3Ali Raza J,Movahed A. Current concepts of cardiovascular disea- ses in diabetes mellitus [ J ]. Int J Cardiol, 2003,89 ( 2 - 3 ) : 123 - 134.
  • 4Zellweger MJ. Prognostic significance of silent coronary artery dis- ease in type 2 diabetes [ J ]. Herz,2006,31 (3) :240 - 245.
  • 5Yamada S, Maruyama I. HMGB-1, a novel infianmmatory cytokine [J].Clin Chim Acta ,2007,375 ( 1 - 2 ) : 36 - 42.
  • 6Yan XX,Lu L,Peng WH,et al. Increased serum HMGB-1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients [J]. Atherosclerosis, 2009,205 ( 2 ) :544 - 548.
  • 7Wang B, Koga K, Osuga Y, et al. High mobility group box 1 (HMGB-1) levels in the placenta and in serum in preeclampsia [J]. Am J Reprod Immunol,2011,66(2) :143 -148.
  • 8Huang W,Tang Y, Li L. HMGB-1, a potent proinflammatory cyto- kine in sepsis [J]. Cytokine ,2010 ,51 (2) :119 - 126.
  • 9盛志新,谢丹红.炎症与2型糖尿病的关系[J].新医学,2008,39(5):345-347. 被引量:32
  • 10张小玲,孙文涛.糖尿病性视网膜病变患者房水中VEGF与IGF-1的定量测定及分析[J].国际眼科杂志,2008,8(5):951-953. 被引量:12

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部